Lijian Liang

[Infiltration of dendritic cells and lymphocytes in hepatocellular carcinoma tissue].

Autologous tumor vaccine lowering postsurgical recurrent rate of hepatocellular carcinoma.

Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus.

Prognostic analysis for treatment modalities in hepatocellular carcinomas with portal vein tumor thrombi.

The roles of Notch1 expression in the migration of intrahepatic cholangiocarcinoma.

Efficacy and safety of the FOLFOX4 regimen versus doxorubicin in Chinese patients with advanced hepatocellular carcinoma: a subgroup analysis of the EACH study.

Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.

Activation of c-Jun predicts a poor response to sorafenib in hepatocellular carcinoma: Preliminary Clinical Evidence.

WAVE3 Induces EMT and Promotes Migration and Invasion in Intrahepatic Cholangiocarcinoma.

Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.

Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience.

Prognostic value of combined preoperative prognostic nutritional index and body mass index in HCC after hepatectomy.

Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients.

WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer.

The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas.

A Case of a Huge Inferior Vena Cava Leiomyosarcoma: Precise Preoperative Evaluation with Gadobutrol-Enhanced MRI.

The role of associating liver partition and portal vein ligation for staged hepatectomy in unresectable hepatitis B virus-related hepatocellular carcinoma.

N-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression.

Overexpression of predicts poor prognosis in patients with cholangiocarcinoma.

Somatic Mutation Profiles Revealed by Next Generation Sequencing (NGS) in 39 Chinese Hepatocellular Carcinoma Patients.

Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma.